The global HPV testing & Pap test market was valued at $ 3655.97 million in 2021, and is projected to reach $ 6647.36 million by 2031, registering a CAGR of 6.1% from 2022 to 2031.
Human Papillomavirus (HPV) is a group of approximately 150 related viruses. These viruses are able to survive in squamous epithelial cells, thus infect cervical and vaginal cells which cause abnormalities in cervical cells leading to cervical or vaginal cancer. In addition, to avoid advanced stage cervical cancer, screening through HPV testing, Pap test or combination of both is recommended. HPV testing is used to detect human Papillomavirus in the cervix, which can lead to cervical cancer. The Pap test is a smear test that provides an accurate screening measure to determine whether cervical cells are abnormal or normal. Individuals who have abnormal cells in their Pap test are advised to have the human Papillomavirus test for further evaluation of cervical cancer.
The driving factors for HPV testing and Pap test market are the increasing number of cervical cancer cases across the globe, and rise in number of cervical cancer screening programs, and the educating people regarding early screening. For instance, according to the report of World Health Organization (WHO) in 2020, stated that more than half a million women contracted cervical cancer, and about 342,000 women died as a result. In addition, WHO’s global strategy for cervical cancer elimination, endorsed by the World Health Assembly in 2020, stated that 70% of women globally to be screened regularly for cervical disease with a high-performance test like HPV test, Pap smear test or combine test i.e., co-test. Further, the growing number of cervical cancer cases increases the demand for screening programs. The persisting burden of cervical cancer in underserved populations and low-resource regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive strategies and expanded screening options to maintain and improve screening coverage further, drives the growth of HPV testing and Pap test market.
However, changes in regulatory guidelines for cervical cancer screening restrains the growth of HPV testing and Pap test market. In addition, availability of human Papillomavirus vaccination across the globe also might hinder the growth of market.
The global HPV testing & Pap test market is segmented into test type, application, location of testing and region. By test type, the market is categorized into HPV test, Pap test and co-test. On the basis of application, the market is segregated into cervical cancer and vaginal cancer. On the basis of location of testing, the market is categorized into hospitals and clinics, diagnostic centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global HPV testing & Pap test market are Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company (BD), F. Hoffmann-La Roche AG, Femasys, Hologic Inc., Mylab Discovery Solutions Pvt. Ltd, Qaigen NV, Seegene Inc and Thermo Fischer Scientific Inc.
Human Papillomavirus (HPV) is a group of approximately 150 related viruses. These viruses are able to survive in squamous epithelial cells, thus infect cervical and vaginal cells which cause abnormalities in cervical cells leading to cervical or vaginal cancer. In addition, to avoid advanced stage cervical cancer, screening through HPV testing, Pap test or combination of both is recommended. HPV testing is used to detect human Papillomavirus in the cervix, which can lead to cervical cancer. The Pap test is a smear test that provides an accurate screening measure to determine whether cervical cells are abnormal or normal. Individuals who have abnormal cells in their Pap test are advised to have the human Papillomavirus test for further evaluation of cervical cancer.
The driving factors for HPV testing and Pap test market are the increasing number of cervical cancer cases across the globe, and rise in number of cervical cancer screening programs, and the educating people regarding early screening. For instance, according to the report of World Health Organization (WHO) in 2020, stated that more than half a million women contracted cervical cancer, and about 342,000 women died as a result. In addition, WHO’s global strategy for cervical cancer elimination, endorsed by the World Health Assembly in 2020, stated that 70% of women globally to be screened regularly for cervical disease with a high-performance test like HPV test, Pap smear test or combine test i.e., co-test. Further, the growing number of cervical cancer cases increases the demand for screening programs. The persisting burden of cervical cancer in underserved populations and low-resource regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive strategies and expanded screening options to maintain and improve screening coverage further, drives the growth of HPV testing and Pap test market.
However, changes in regulatory guidelines for cervical cancer screening restrains the growth of HPV testing and Pap test market. In addition, availability of human Papillomavirus vaccination across the globe also might hinder the growth of market.
The global HPV testing & Pap test market is segmented into test type, application, location of testing and region. By test type, the market is categorized into HPV test, Pap test and co-test. On the basis of application, the market is segregated into cervical cancer and vaginal cancer. On the basis of location of testing, the market is categorized into hospitals and clinics, diagnostic centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global HPV testing & Pap test market are Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company (BD), F. Hoffmann-La Roche AG, Femasys, Hologic Inc., Mylab Discovery Solutions Pvt. Ltd, Qaigen NV, Seegene Inc and Thermo Fischer Scientific Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hpv testing & pap test market analysis from 2021 to 2031 to identify the prevailing hpv testing & pap test market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the hpv testing & pap test market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global hpv testing & pap test market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
- HPV test
- Pap Test
- Co-test
By Application
- Cervical Cancer
- Vaginal Cancer
By Location of Testing
- Hospitals and clinics
- Diagnostic Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Arbor vita corporation
- Becton, Dickinson and Company
- Femasys Inc.
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Mylab Discovery Solutions Pvt. Ltd
- Seegene Inc
- Hologic Inc.
- F. Hoffmann-La Roche AG
- Qaigen NV
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Government initiatives and funding for cervical cancer
3.4.1.2. Increase in prevalence of cervical cancer cases
3.4.1.3. Increase in awareness regarding cervical cancer
3.4.2. Restraints
3.4.2.1. Human papillomavirus vaccination
3.4.2.2. Changes in regulatory guidelines and uncertain reimbursement schemes for cervical cancer
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: HPV TESTING & PAP TEST MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2. HPV test
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Pap Test
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Co-test
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: HPV TESTING & PAP TEST MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2. Cervical Cancer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Vaginal Cancer
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING
6.1 Overview
6.1.1 Market size and forecast
6.2. Hospitals and clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Diagnostic Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: HPV TESTING & PAP TEST MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Test Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by Location of Testing
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Test Type
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by Location of Testing
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Test Type
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by Location of Testing
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Test Type
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by Location of Testing
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Test Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by Location of Testing
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Test Type
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by Location of Testing
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Test Type
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by Location of Testing
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Test Type
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by Location of Testing
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Test Type
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by Location of Testing
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Test Type
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by Location of Testing
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Test Type
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by Location of Testing
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Test Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by Location of Testing
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Test Type
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by Location of Testing
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Test Type
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by Location of Testing
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Test Type
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by Location of Testing
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Test Type
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by Location of Testing
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Test Type
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by Location of Testing
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Test Type
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by Location of Testing
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Test Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by Location of Testing
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Test Type
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by Location of Testing
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Test Type
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by Location of Testing
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Test Type
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by Location of Testing
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Test Type
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by Location of Testing
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Arbor vita corporation
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 Becton, Dickinson and Company
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 Femasys Inc.
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Abbott Laboratories
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 Thermo Fisher Scientific Inc.
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Mylab Discovery Solutions Pvt. Ltd
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 Seegene Inc
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Hologic Inc.
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 F. Hoffmann-La Roche AG
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 Qaigen NV
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments
List of Tables
Table 1. Global Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 2. Hpv Testing & Pap Test Market for Hpv Test, by Region, 2021-2031 (Revenue, $Million)
Table 3. Hpv Testing & Pap Test Market for Pap Test, by Region, 2021-2031 (Revenue, $Million)
Table 4. Hpv Testing & Pap Test Market for Co-Test, by Region, 2021-2031 (Revenue, $Million)
Table 5. Global Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 6. Hpv Testing & Pap Test Market for Cervical Cancer, by Region, 2021-2031 (Revenue, $Million)
Table 7. Hpv Testing & Pap Test Market for Vaginal Cancer, by Region, 2021-2031 (Revenue, $Million)
Table 8. Global Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 9. Hpv Testing & Pap Test Market for Hospitals and Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 10. Hpv Testing & Pap Test Market for Diagnostic Centers, by Region, 2021-2031 (Revenue, $Million)
Table 11. Hpv Testing & Pap Test Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 12. Hpv Testing & Pap Test Market, by Region, 2021-2031 (Revenue, $Million)
Table 13. North America Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 14. North America Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 15. North America Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 16. North America Hpv Testing & Pap Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 17. U.S. Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 18. U.S. Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 19. U.S. Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 20. Canada Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 21. Canada Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 22. Canada Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 23. Mexico Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 24. Mexico Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 25. Mexico Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 26. Europe Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 27. Europe Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 28. Europe Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 29. Europe Hpv Testing & Pap Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 30. Germany Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 31. Germany Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 32. Germany Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 33. France Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 34. France Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 35. France Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 36. UK Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 37. UK Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 38. UK Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 39. Italy Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 40. Italy Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 41. Italy Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 42. Spain Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 43. Spain Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 44. Spain Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 45. Rest of Europe Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 48. Asia-Pacific Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Hpv Testing & Pap Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 52. Japan Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 53. Japan Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 54. Japan Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 55. China Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 56. China Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 57. China Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 58. India Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 59. India Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 60. India Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 61. Australia Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 62. Australia Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 63. Australia Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 64. South Korea Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 65. South Korea Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 66. South Korea Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 67. Rest of Asia-Pacific Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 70. LAMEA Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Hpv Testing & Pap Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 74. Brazil Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 75. Brazil Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 76. Brazil Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 77. Saudi Arabia Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 80. South Africa Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 81. South Africa Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 82. South Africa Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 83. Rest of LAMEA Hpv Testing & Pap Test Market, by Test Type, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Hpv Testing & Pap Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Hpv Testing & Pap Test Market, by Location of Testing, 2021-2031 (Revenue, $Million)
Table 86. Arbor Vita Corporation: Key Executives
Table 87. Arbor Vita Corporation: Company Snapshot
Table 88. Arbor Vita Corporation: Operating Segments
Table 89. Arbor Vita Corporation: Product Portfolio
Table 90. Arbor Vita Corporation: Net Sales
Table 91. Arbor Vita Corporation: Key Stratergies
Table 92. Becton, Dickinson and Company: Key Executives
Table 93. Becton, Dickinson and Company: Company Snapshot
Table 94. Becton, Dickinson and Company: Operating Segments
Table 95. Becton, Dickinson and Company: Product Portfolio
Table 96. Becton, Dickinson and Company: Net Sales
Table 97. Becton, Dickinson and Company: Key Stratergies
Table 98. Femasys Inc.: Key Executives
Table 99. Femasys Inc.: Company Snapshot
Table 100. Femasys Inc.: Operating Segments
Table 101. Femasys Inc.: Product Portfolio
Table 102. Femasys Inc.: Net Sales
Table 103. Femasys Inc.: Key Stratergies
Table 104. Abbott Laboratories: Key Executives
Table 105. Abbott Laboratories: Company Snapshot
Table 106. Abbott Laboratories: Operating Segments
Table 107. Abbott Laboratories: Product Portfolio
Table 108. Abbott Laboratories: Net Sales
Table 109. Abbott Laboratories: Key Stratergies
Table 110. Thermo Fisher Scientific Inc.: Key Executives
Table 111. Thermo Fisher Scientific Inc.: Company Snapshot
Table 112. Thermo Fisher Scientific Inc.: Operating Segments
Table 113. Thermo Fisher Scientific Inc.: Product Portfolio
Table 114. Thermo Fisher Scientific Inc.: Net Sales
Table 115. Thermo Fisher Scientific Inc.: Key Stratergies
Table 116. Mylab Discovery Solutions Pvt. Ltd: Key Executives
Table 117. Mylab Discovery Solutions Pvt. Ltd: Company Snapshot
Table 118. Mylab Discovery Solutions Pvt. Ltd: Operating Segments
Table 119. Mylab Discovery Solutions Pvt. Ltd: Product Portfolio
Table 120. Mylab Discovery Solutions Pvt. Ltd: Net Sales
Table 121. Mylab Discovery Solutions Pvt. Ltd: Key Stratergies
Table 122. Seegene Inc: Key Executives
Table 123. Seegene Inc: Company Snapshot
Table 124. Seegene Inc: Operating Segments
Table 125. Seegene Inc: Product Portfolio
Table 126. Seegene Inc: Net Sales
Table 127. Seegene Inc: Key Stratergies
Table 128. Hologic Inc.: Key Executives
Table 129. Hologic Inc.: Company Snapshot
Table 130. Hologic Inc.: Operating Segments
Table 131. Hologic Inc.: Product Portfolio
Table 132. Hologic Inc.: Net Sales
Table 133. Hologic Inc.: Key Stratergies
Table 134. F. Hoffmann-La Roche Ag: Key Executives
Table 135. F. Hoffmann-La Roche Ag: Company Snapshot
Table 136. F. Hoffmann-La Roche Ag: Operating Segments
Table 137. F. Hoffmann-La Roche Ag: Product Portfolio
Table 138. F. Hoffmann-La Roche Ag: Net Sales
Table 139. F. Hoffmann-La Roche Ag: Key Stratergies
Table 140. Qaigen Nv: Key Executives
Table 141. Qaigen Nv: Company Snapshot
Table 142. Qaigen Nv: Operating Segments
Table 143. Qaigen Nv: Product Portfolio
Table 144. Qaigen Nv: Net Sales
Table 145. Qaigen Nv: Key Stratergies
List of Figures
Figure 1. Segmentation of Hpv Testing & Pap Test Market, 2021-2031
Figure 2. Hpv Testing & Pap Test Market, 2021-2031
Figure 3. Top Investment Pockets, by Region
Figure 4. Porter Five-1
Figure 5. Porter Five-2
Figure 6. Porter Five-3
Figure 7. Porter Five-4
Figure 8. Porter Five-5
Figure 9. Hpv Testing & Pap Test Market: Drivers, Restraints and Opportunities
Figure 10. Hpv Testing & Pap Test Market, by Test Type, 2021 (%)
Figure 11. Comparative Share Analysis of Hpv Test Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 12. Comparative Share Analysis of Pap Test Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 13. Comparative Share Analysis of Co-Test Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 14. Hpv Testing & Pap Test Market, by Application, 2021 (%)
Figure 15. Comparative Share Analysis of Cervical Cancer Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 16. Comparative Share Analysis of Vaginal Cancer Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 17. Hpv Testing & Pap Test Market, by Location of Testing, 2021 (%)
Figure 18. Comparative Share Analysis of Hospitals and Clinics Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 19. Comparative Share Analysis of Diagnostic Centers Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 20. Comparative Share Analysis of Others Hpv Testing & Pap Test Market, 2021 and 2031 (%)
Figure 21. Hpv Testing & Pap Test Market by Region, 2021
Figure 22. U.S. Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 23. Canada Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 24. Mexico Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 25. Germany Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 26. France Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 27. UK Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 28. Italy Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 29. Spain Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 30. Rest of Europe Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 31. Japan Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 32. China Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 33. India Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 34. Australia Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 35. South Korea Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 36. Rest of Asia-Pacific Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 37. Brazil Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 38. Saudi Arabia Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 39. South Africa Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 40. Rest of LAMEA Hpv Testing & Pap Test Market, 2021-2031 ($Million)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap of Top 10 Key Players
Figure 47. Top Player Positioning, 2021
Figure 48. Arbor Vita Corporation.: Net Sales ($Million)
Figure 49. Becton, Dickinson and Company.: Net Sales ($Million)
Figure 50. Femasys Inc..: Net Sales ($Million)
Figure 51. Abbott Laboratories.: Net Sales ($Million)
Figure 52. Thermo Fisher Scientific Inc..: Net Sales ($Million)
Figure 53. Mylab Discovery Solutions Pvt. Ltd.: Net Sales ($Million)
Figure 54. Seegene Inc.: Net Sales ($Million)
Figure 55. Hologic Inc..: Net Sales ($Million)
Figure 56. F. Hoffmann-La Roche Ag.: Net Sales ($Million)
Figure 57. Qaigen Nv.: Net Sales ($Million)
Executive Summary
According to the report titled, “HPV Testing & Pap Test Market," The hpv testing & pap test market was valued at $3.7 billion in 2021, and is estimated to reach $6.7 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.The HPV testing and Pap test Market is likely to experience a significant growth rate of 6.1% from 2022-2031 owing to increasing market demand from pharmaceutical sector.
Human Papillomavirus is associated with a variety of clinical conditions that range from innocuous lesions to cancer. In addition, out of the many types of human papillomavirus (HPV), more than 30 infect genital tract. The association between certain oncogenic (HPV 16 &18) strains of HPV and cervical cancer is well known and established. In addition, early diagnosis and treatment of precancerous lesions can prevent progression to cervical cancer. Further, three tests have been recommended for cervical cancer screening such as HPV test, Pap test or combination of both I.e., co-test.
Key factors driving the growth of the HPV testing and Pap test market include rise in prevalence of cervical cancer cases and increase in HPV 16 infections among women. For instance, according to article published in HPV Information Centre - Kenya 2021, stated that, 9.1% of women in the general population are estimated to cervical HPV-16/18 infection at a given time, and 63.1% of invasive cervical cancers are attributed to HPVs 16 or 18. In many regions, rise in prevalence of vaginal cancer cases is seen because of human papillomavirus infections which leads to rise in demand of screening tests which fuels the growth of market. Further, adoption of combination of HPV and Pap test for accurate screening of vaginal and cervical cancer boosts the growth of market. Furthermore, rise in preference of self-sampling screening tests for detection of cervical cancer drives the growth of market during forecast period.
The market also offers growth opportunities to the key players in the market. Many developing regions such India, China and U.S. offer lucrative opportunities to key players of HPV testing and Pap test market owing to high population base, increase in demand of advanced screening test kits and increase in healthcare spending.
The global HPV testing & Pap test market is segmented into test type, application, location of testing and region. By test type, the market is categorized into HPV test, pap test and co-test. On the basis of application, the market is segregated into cervical cancer and vaginal cancer. On the basis of location of testing, the market is categorized into hospitals and clinics, diagnostic centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global HPV testing and Pap test market are Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company (BD), F. Hoffmann-La Roche AG, Femasys, Hologic Inc., Mylab Discovery Solutions Pvt. Ltd, Qaigen NV, Seegene Inc and Thermo Fischer Scientific Inc. The players in the market have been actively engaged in the adoption various strategies such as product launch and product approval to remain competitive and gain advantage over the competitors in the market. For instance, in May 2021, Hologic, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted market approval for Company’s ThinPrep GenesisTM processor for cytology processing and cervical cancer screening.
Key Market Insights (Updated)
- By test type, the pap test segment was highest revenue contributor to the market and is estimated to reach $23583.35 million by 2031, with a CAGR of 5.8%. However, co-test segment is anticipated to grow at CAGR of 8.6% during the forecast period.
- By application, cervical cancer segment is the largest revenue-generating segment and is anticipated to grow at CAGR of 6.3% segment during forecast period.
- On the basis of location of testing, the diagnostic centers segment dominated the market in 2021. However, Others are anticipated to grow at the highest CAGR of 6.7% during the forecast period.
- Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Arbor vita corporation
- Becton, Dickinson and Company
- Femasys Inc.
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Mylab Discovery Solutions Pvt. Ltd
- Seegene Inc
- Hologic Inc.
- F. Hoffmann-La Roche AG
- Qaigen NV
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 208 |
| Published | December 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 3655.97 million |
| Forecasted Market Value ( USD | $ 6647.36 million |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
